Patent Assignment
Reel/Frame 059214/0775
Assignment of Assignor's Interest
Recorded: 2022-03-09
Pages: 7
Assignee
STEMIMMUNE, INCORPORATED
3655 NOBEL DRIVE, SAN DIEGO, CALIFORNIA, 92122
Covered Property
(1)
Combination Immunotherapy Approach for Treatment of Cancer
Application:
17/689,643 →
Publication:
US US20220241388A1
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Merger
Mar 9, 2022
From: CALIDI BIOTHERAPEUTICS, INC.
To: CALIDI BIOTHERAPEUTICS, INC.
Reel/Frame 059214/0829 →
Change of Name
Mar 9, 2022
From: STEMIMMUNE, INC.
To: CALIDI BIOTHERAPEUTICS, INC.
Reel/Frame 059357/0545 →
Change of Name
May 1, 2024
From: CALIDI BIOTHERAPEUTICS, INC.
To: CALIDI BIOTHERAPEUTICS (NEVADA), INC.
Reel/Frame 067285/0965 →